These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12957826)

  • 1. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta.
    Huang X; Lee C
    Front Biosci; 2003 Sep; 8():s740-9. PubMed ID: 12957826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
    Cohen P; Nunn SE; Peehl DM
    J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cells of the human prostate: initial isolation and characterization.
    Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
    Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
    Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
    Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and differentiation of prostatic stromal cells.
    Niu Y; Xu Y; Zhang J; Bai J; Yang H; Ma T
    BJU Int; 2001 Mar; 87(4):386-93. PubMed ID: 11251536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia.
    Li Y; Li J; Zhou L; Wang Z; Jin L; Cao J; Xie H; Wang L
    Cell Commun Signal; 2024 May; 22(1):257. PubMed ID: 38711089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N; Tu H; Jacobs SC
    Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of bFGF and TGF-beta1 in primary cultured prostatic stromal cells].
    Gu H; Dong ZX; Wang CB; Yuan YF; Hou JH
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):917-22. PubMed ID: 17121024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK; Nanda J; Chapman KE; Habib FK
    J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.
    Alonso-Magdalena P; Brössner C; Reiner A; Cheng G; Sugiyama N; Warner M; Gustafsson JA
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2859-63. PubMed ID: 19196965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta in benign and malignant prostate.
    Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
    Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aetiology and pathogenesis of benign prostatic hyperplasia.
    Eaton CL
    Curr Opin Urol; 2003 Jan; 13(1):7-10. PubMed ID: 12490809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
    Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
    Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
    Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
    Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
    Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
    Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.